University of Florida
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Florida sits in the top decile of US sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count).
University of Florida: 1,106 sponsored US clinical trials, 170 recruiting.
University of Florida sponsors 1,106 registered US clinical trials on ClinicalTrials.gov, 170 of them currently recruiting, and 754 completed. 103 of these trials are in Phase 3-4 (later-stage) and 232 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Coronary Artery Disease, with 17 trials.
Top-decile sponsor footprint
University of Florida ranks in the top decile of sponsors by registered trial count (#29 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
754 of 855 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,106 total, page 2 of 23
Journaling Intervention for Temporomandibular Disorder (TMD) and Chronic Overlapping Pain
NCT06977100
Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Peripheral Neuropathy (CIPN)
NCT07009717
Neurophysiology of Locomotor Adaptation and Freezing of Gait in Parkinson's Disease
NCT06911229
The Study of Urinary Biomarkers in Patients With Hypomagnesemia
NCT07056283
A Behavioral mHealth Intervention for People With HIV With Anxiety and Depression
NCT07112001
Yeast Mannans and Stool Frequency
NCT06911177
Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers
NCT06851936
Group Integrative Breathwork for Chronic Pain
NCT06977984
ClAmpless, Sutureless PartIAl Nephrectomy for Renal Masses
NCT06722807
The Impact of Deep Brain Stimulation on Speech and Swallow Function in Parkinson Disease
NCT07026734
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
NCT05655494
High Intensity Focused Ultrasound in Prostate Cancer
NCT06402357
BFRT for Subacromial Pain
NCT06873113
A Mediation Analysis Investigating Dry Needling Treatment Mechanisms in a Chronic Low Back Pain Population
NCT06940492
A Media Parenting Prevention Intervention
NCT05332275
The PROACTIVE Study for Black Elders
NCT06512727
Circadian Adaptive DBS in Essential Tremor
NCT06635811
Physical and Cognitive Aging Study in Older Adults
NCT06726616
Trial of Precision Medicine in Emergency Departments
NCT06448091
Comparison of Dual Antiplatelet Therapy De-escalation by Dose Reduction Versus Switching in Patients Undergoing PCI: The Switching Antiplatelet-8 (SWAP-8) Study
NCT06821191
Can Near-Infrared Spectroscopy (NIRS) or Intramuscular Glucose Levels Detect Impaired Leg Compartment' Perfusion?
NCT06512870
Potential Benefits of Parent Child Interaction Therapy (PCIT)
NCT06827951
The Role of Brain-Bone Marrow-Gut Interaction Following Major Trauma
NCT06606119
Spinal Networks of Balance Learning and Retention in Older Adults
NCT06517043
Antihypertensive Mechanisms of Minocycline in Resistant Hypertension
NCT06246396
Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors
NCT06691191
Use of CBD in the Treatment of Anxiety
NCT06672666
Modernizing Instructions to Improve Treatment Participation of Subjects During Their First Radiotherapy
NCT06246409
Perspectives on Spinal Manipulative Therapy for Low Back Pain
NCT06590116
OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd Trial
NCT06558214
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
NCT06535139
Listening to Calming Music
NCT06710886
AD HOC Trial: Artificial Intelligence-Based Drug Dosing In Hepatocellular Carcinoma
NCT05669339
Preoperative Nicotine Cessation for Women With Breast Cancer Recommended for Reconstruction
NCT06461650
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
NCT06488222
The Switching Antiplatelet-9 (SWAP-9) Study
NCT06588595
Integrative Breathwork Intervention for Chronic Pain
NCT06546956
A Study Evaluating the Feasibility and Compliance of Manual Lymphatic Drainage Comparing Indocyanine-Green (ICG) Guided vs. Traditional Guided in Patients Undergoing Axillary Node Dissection for the Treatment of Breast Cancer
NCT06327490
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
NCT05457725
Transdiagnostic Intervention to Reduce Internalized Health-Related Stigma
NCT05561595
Mobile Video Directly Observed Therapy (DOT) for Immunosuppression Medication Adherence in Adolescent Heart Transplant Recipients
NCT05732779
UFPTI 2403-PR12: Real-Time Volumetric Ionizing Radiation Acoustic Imaging for In-vivo Proton Treatment Monitoring in Pencil-Beam Scanning
NCT06465966
Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy
NCT06184516
Intermittent Visual Perturbations to Enhance Balance Training
NCT06804512
CBD for Knee Osteoarthritis
NCT06414473
Project CONTINUITY: Promoting Evidence-Based Cancer Screening Among Underserved Women
NCT05390567
The Potential of Kava in Enabling Tobacco Cessation - Its Holistic Effects in Managing Stress and Insomnia Associated With Abstinence
NCT05814055
Self-management of Low Back Pain in Horticulture Workers
NCT06153199
Vasodilator and Exercise Study for DMD (VASO-REx)
NCT06290713
Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases
NCT05800210
What is open in the University of Florida pipeline
170 recruiting of 1,106 indexed (15% open); 754 completed (68%).
Phase mix: 103 late (III/IV) vs 232 early (I/II) (early-phase heavy).
Top condition: Coronary Artery Disease (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Florida: open-pipeline peers nationwide
Peers matched on 1,106 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Florida sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,106 trials (± recruiting share)
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- NYU Langone Health · 1,164 trials · 17% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Arrowhead Regional Medical Center · 15% recruiting · 13 trials
- Aurinia Pharmaceuticals · 15% recruiting · 13 trials
- Bronx VA Medical Center · 15% recruiting · 13 trials
- Candel Therapeutics · 15% recruiting · 13 trials
Related
What to do with this University of Florida page
1,106 registered trials is a research-attention snapshot, not an endorsement of University of Florida or any single study.
- 170 of University of Florida's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Coronary Artery Disease is the condition University of Florida studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Coronary Artery Disease trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Florida pipeline card: 1,106 registered trials from official public datasets.Report a data error.